Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Where’s Garr? Where is any leader of CUBT at?
Update! Access granted to #OTC
— the 1 & Only HANS (@The1OnlyHans) May 16, 2024
Let's get current! Stand by $medh SH.
Here we grow again!
— the 1 & Only HANS (@The1OnlyHans) May 14, 2024
New location @lazydazeco coming to San Antonio. https://t.co/sauhfRhlKw
JOIN THE REBELLION!$MEDH pic.twitter.com/Di5a0iCCeA
SH Update from $medh #CEO
— the 1 & Only HANS (@The1OnlyHans) May 14, 2024
OTC annual fee paid and cleared.
Pending login creds for OTCIQ.
Stand by for Qreport uploads and profile updates.#OTC
Load the Q’s, K, and Financials!!!
Dear $Medh,
— the 1 & Only HANS (@The1OnlyHans) May 8, 2024
Thank you for your patience. At this time we can confirm the Transfer Agent information is in good standing & are sending the DNS annual invoice. Please let me know if you have not received it by the end of & I will reach out to our billing department. From #OTC
Suspicious. I’m speculating some negative results behind the scenes from another study or something… that will hinder advancing their initiative… or why else dilute and create zero shareholder wealth.
Skipping 2 and going to Schedule 3!!!!!
https://apnews.com/article/marijuana-biden-dea-criminal-justice-pot-f833a8dae6ceb31a8658a5d65832a3b8
Cannabis schedule 2 soon! And MEDH not ready
Hans is going to miss the cannabis re-scheduling by DEA!! Call him and get it stressed to get current
Update $medh: From OTC - Background checks are in good standing, & am reaching out to Sig Stock Transfer & Jason to confirm the Transfer Agent feed is in good standing. Once confirmed we will invoice the annual fee & send the IQ Agreement to finalize the application approval.
— the 1 & Only HANS (@The1OnlyHans) April 24, 2024
This group took a fantastic shell 3 years ago and have only decimated its structure.
Massive dilution last 3-4 years.
Outstanding Shares
903,263,385
04/12/2024
More shares to be diluted soon.
Considering setting up a company with one pothead (cannabis user) to be a part-time dog walker and then just gift that company to Hans so he can at least show some revenue on the books.
Since we got the time… anyone suggest a good name for the Company?
Puff & Paws 🐾 Walkers
Bongs & Bark
2 to 52 more weeks to go!
What’s the problem here? Literally no ophthalmic company wants in at the starting line?
Not one interested investor to lift the company up?
Q1 coming and going
They are diluting everyone out of their longterm positions. Expecting Billion OS soon
Outstanding Shares
903,263,385
03/04/2024
Unsure if that’s accurate, shows 200 mil shares increased on OS
https://www.otcmarkets.com/stock/CUBT/security
Outstanding Shares
703,263,385
02/15/2024
They haven’t updated this but I’m guessing the next time they do it will show more dilution
They are diluting more shares.
Guess Aegis Capital Corp. couldn’t get it done.
Garr and Michaels funding issues? Should be a slam dunk with two active drug programs
More dilution? Or iRobert selling the newly bought shares?
The 160 million shares diluted though now explains why we could never arrive to a higher SP.
I hope they stop the bleeding…
Nice buying iRobot! Glad you loaded up more shares! That shows conviction!
And the OS continues to grow as they dilute.
Outstanding Shares
703,263,385
02/15/2024
No funding news yet.
The audacity… that’s exactly how not to attract investors with silly RS talk.
Can’t even get current nor file official financial and says that.
Get 10-20 unit’s operating with a valid accounting team then talk like that.
awesome to see we have a CD56 monoclonal antibody product $$$$$$
https://www.acrobiosystems.com/L-1666-CD56.html?gad_source=1&gclid=EAIaIQobChMIibSKjb-whAMVczrUAR3DbA-BEAAYASAAEgJGWfD_BwE
Name Research Code Research Phase Company Indications Clinical Trials
Lorvotuzumab mertansine BB-10901; IMGN-901; huN-901-DM1; IMGN-901-TAP; huN-901-SPP-DM1 Phase 2 Clinical Immunogen Inc Ovarian Neoplasms; Leukemia; Rhabdomyosarcoma; Carcinoma, Merkel Cell; Small Cell Lung Carcinoma; Wilms Tumor; Multiple Myeloma; Sarcoma, Synovial; Neurofibrosarcoma; Neuroblastoma; Carcinoma, Small Cell
Details
GD2/CD56 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute) bi-4SCAR GD2/CD56 Phase 2 Clinical Shenzhen Geno-Immune Medical Institute Neoplasms
Details
CUBT-906 CUBT-906 Phase 2 Clinical Curative Biotechnology Inc
Load up and check this out!
CD56
Brief Information
Name:Neural cell adhesion molecule 1
Target Synonym:Neural cell adhesion molecule 1,CD56,NCAM1,NCAM,Neural Cell Adhesion Molecule, NCAM,CD56 Antigen,N-CAM-1,MSK39,NCAM-1,Antigen Recognized By Monoclonal Antibody 5.1H11
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 2 Clinical
Yep. Very true! Lol
Have to hope Hans has Financials prepared and ready to submit. Once revenue is transparent that will be a game changer!
Mitesco shareholder update
https://finance.yahoo.com/news/mitesco-provides-shareholder-141200469.html
Any chance our CEO’s Paul and Richard can take a nice professional headshot for their LinkedIn photos and CUBT website?
Paul looks like he’s wearing a robe until you look closely and Richard looks like he took it himself and is looking away.
Upgrade them pics of our leaders!
Optimistic to think we go $0.30 with two drug programs
Could they be building the cancer drug up as a stepping stone into the metformin filing? Two optimistic drug programs could drive this >$0.75 …
Curative Biotechnology funding and FDA IND application soon? When ?
Dilution = Pollution